Steward Partners Investment Advisory, LLC Biotechnology

Steward Partners Investment Advisory, LLC

$11 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$132B	$16 Million 0.15% of portfolio	39,808	Q4 2024 Reduced 11.06%
NVO Novo Nordisk A S	$181B	$11.1 Million 0.1% of portfolio	128,980	Q4 2024 Reduced 28.92%
VKTX Viking Therapeutics, Inc.	$2.37B	$9.03 Million 0.08% of portfolio	224,409	Q4 2024 Added 41.99%
APLS Apellis Pharmaceuticals, Inc.	$2.76B	$3.67 Million 0.03% of portfolio	115,045	Q4 2024 Added 1.99%
REGN Regeneron Pharmaceuticals, Inc.	$72.7B	$3.3 Million 0.03% of portfolio	4,627	Q4 2024 Added 26.91%
RNA Avidity Biosciences, Inc.	$1.76B	$1.41 Million 0.01% of portfolio	48,450	Q4 2024 Reduced 48.25%
CRMD Cor Medix Inc.	$431M	$1.21 Million 0.01% of portfolio	149,834	Q4 2024 Added 2.2%
CORT Corcept Therapeutics Inc	$6.2B	$617,000 0.01% of portfolio	12,250	Q4 2024 Added 1.14%
ROIV Roivant Sciences Ltd.	$7.64B	$259,000 0.0% of portfolio	21,953	Q4 2024 New
UTHR United Therapeutics Corp	$14.7B	$238,000 0.0% of portfolio	675	Q4 2024 Added 29.81%
EXEL Exelixis, Inc.	$11.9B	$234,000 0.0% of portfolio	7,050	Q4 2024 Added 4.91%
ARGX Argenx Se	$34B	$233,000 0.0% of portfolio	380	Q4 2024 Added 5.56%
BPMC Blueprint Medicines Corp	$5.5B	$227,000 0.0% of portfolio	2,610	Q4 2024 Reduced 22.11%
ALNY Alnylam Pharmaceuticals, Inc.	$31.1B	$221,000 0.0% of portfolio	940	Q4 2024 Added 4.44%
ALT Altimmune, Inc.	$293M	$202,000 0.0% of portfolio	28,050	Q4 2024 Added 38.86%
ETNB 89bio, Inc.	$394M	$155,000 0.0% of portfolio	20,210	Q4 2024 Reduced 74.85%
TECH Bio Techne Corp	$2.45B	$153,000 0.0% of portfolio	2,137	Q4 2024 Added 14.34%
IOVA Iovance Biotherapeutics, Inc.	$590M	$138,000 0.0% of portfolio	18,679	Q4 2024 Added 83.18%
MRNA Moderna, Inc.	$13.6B	$131,000 0.0% of portfolio	3,162	Q4 2024 Reduced 33.38%
BGNE Bei Gene, Ltd.	$23.5B	$130,000 0.0% of portfolio	707	Q4 2024 Added 1.14%
MIRM Mirum Pharmaceuticals, Inc.	$1.66B	$115,000 0.0% of portfolio	2,800	Q4 2024 Reduced 67.68%
RPRX Royalty Pharma PLC	$14.4B	$113,000 0.0% of portfolio	4,431	Q4 2024 Added 806.13%
IONS Ionis Pharmaceuticals Inc	$4.87B	$107,000 0.0% of portfolio	3,074	Q4 2024 Added 49.59%
BMRN Biomarin Pharmaceutical Inc	$13.3B	$98,000 0.0% of portfolio	1,506	Q4 2024 Added 60.9%
RXRX Recursion Pharmaceuticals, Inc.	$1.23B	$98,000 0.0% of portfolio	14,565	Q4 2024 Added 217.8%
RCKT Rocket Pharmaceuticals, Inc.	$668M	$84,000 0.0% of portfolio	6,700	Q4 2024 Reduced 21.18%
MNKD Mannkind Corp	$1.35B	$81,000 0.0% of portfolio	12,627	Q4 2024 Reduced 53.97%
RARE Ultragenyx Pharmaceutical Inc.	$2.78B	$71,000 0.0% of portfolio	1,710	Q4 2024 Added 2.09%
INCY Incyte Corp	$13.8B	$60,000 0.0% of portfolio	871	Q4 2024 Added 2.96%
LQDA Liquidia Corp	$929M	$58,000 0.0% of portfolio	5,000	Q4 2024 New
ARDX Ardelyx, Inc.	$841M	$50,000 0.0% of portfolio	9,728	Q1 2024 Added 462.96%
BNTX Bio N Tech Se	$24.5B	$48,000 0.0% of portfolio	425	Q4 2024 Added 13.33%
SMMT Summit Therapeutics Inc.	$4.04B	$44,000 0.0% of portfolio	2,503	Q4 2024 Added 56.14%
ADMA Adma Biologics, Inc.	$3.67B	$38,000 0.0% of portfolio	2,262	Q4 2024 Reduced 80.21%
SRPT Sarepta Therapeutics, Inc.	$8.88B	$37,000 0.0% of portfolio	312	Q4 2024 Added 164.41%
CRSP Crispr Therapeutics Ag	$3.34B	$33,000 0.0% of portfolio	861	Q4 2024 Reduced 9.18%
BBIO Bridge Bio Pharma, Inc.	$4.89B	$28,000 0.0% of portfolio	1,022	Q4 2024 Added 85.82%
INSM Insmed Inc	$10.5B	$28,000 0.0% of portfolio	413	Q4 2024 Added 65.2%
CPRX Catalyst Pharmaceuticals, Inc.	$2.24B	$26,000 0.0% of portfolio	1,273	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$422M	$26,000 0.0% of portfolio	6,500	Q4 2024 Added 160.0%
CYTK Cytokinetics Inc	$4.23B	$23,000 0.0% of portfolio	500	Q3 2024 New
HALO Halozyme Therapeutics, Inc.	$8.77B	$23,000 0.0% of portfolio	500	Q4 2024 Reduced 2.53%
ORMP Oramed Pharmaceuticals Inc.	$92.8M	$21,000 0.0% of portfolio	8,826	Q1 2024 New
RVMD Revolution Medicines, Inc.	$3.43B	$19,000 0.0% of portfolio	450	Q4 2024 New
XLO Xilio Therapeutics, Inc.	$22.8M	$19,000 0.0% of portfolio	20,000	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$728M	$16,000 0.0% of portfolio	1,443	Q4 2024 Reduced 5.69%
DYN Dyne Therapeutics, Inc.	$624M	$14,000 0.0% of portfolio	610	Q4 2024 Added 62.67%
GERN Geron Corp	$657M	$14,000 0.0% of portfolio	4,000	Q2 2024 Added 100.0%
VERA Vera Therapeutics, Inc.	$757M	$14,000 0.0% of portfolio	350	Q4 2024 New
TBPH Theravance Biopharma, Inc.	$624M	$14,000 0.0% of portfolio	1,500	Q1 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.